BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19198880)

  • 1. Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt.
    Elsheikha HM; Azab MS; Abousamra NK; Rahbar MH; Elghannam DM; Raafat D
    Parasitol Res; 2009 Jun; 104(6):1471-6. PubMed ID: 19198880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Toxoplasma gondii, risk factors and knowledge about toxoplasmosis in undergraduate students from Lima, Peru.
    Jimenez-Chunga J; Gomez-Puerta LA; Vargas-Calla A; Castro-Hidalgo J; Sánchez-Chicana C; Calderón-Sánchez M
    Acta Trop; 2024 Jul; 255():107233. PubMed ID: 38723738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades.
    Jones JL; Kruszon-Moran D; Rivera HN; Price C; Wilkins PP
    Am J Trop Med Hyg; 2014 Jun; 90(6):1135-9. PubMed ID: 24710615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Toxoplasma gondii seropositivity and memory function in nondemented older adults.
    Wyman CP; Gale SD; Hedges-Muncy A; Erickson LD; Wilson E; Hedges DW
    Neurobiol Aging; 2017 May; 53():76-82. PubMed ID: 28235681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between antibodies to neurotropic pathogens and bipolar disorder : A study in the Dutch Bipolar (DB) Cohort and meta-analysis.
    Snijders GJLJ; van Mierlo HC; Boks MP; Begemann MJH; Sutterland AL; Litjens M; Ophoff RA; Kahn RS; de Witte LD
    Transl Psychiatry; 2019 Nov; 9(1):311. PubMed ID: 31748521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent Toxoplasma gondii infections are associated with elevated biomarkers of inflammation and vascular injury.
    Egorov AI; Converse RR; Griffin SM; Styles JN; Sams E; Hudgens E; Wade TJ
    BMC Infect Dis; 2021 Feb; 21(1):188. PubMed ID: 33602170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasma gondii Infections and Associated Factors in Female Children and Adolescents, Germany.
    Giese L; Seeber F; Aebischer A; Kuhnert R; Schlaud M; Stark K; Wilking H
    Emerg Infect Dis; 2024 May; 30(5):995-999. PubMed ID: 38666641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of Toxoplasma gondii IgG and cognitive function scores: NHANES 2013-2014.
    Wiener RC; Waters C; Bhandari R
    Parasitol Int; 2020 Oct; 78():102123. PubMed ID: 32416258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based cohort study of Toxoplasma gondii P22 antibody positivity correlation with anxiety.
    Yang L; Wang B; Wu S; Yang Z; Xin Z; Zheng S; Zou W; Zhang C; Chen J; Peng H
    J Affect Disord; 2024 Aug; 359():41-48. PubMed ID: 38729222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between toxoplasmosis and schizophrenia in Egyptian patients and its impact on dopamine serum levels.
    Ammar AM; Nabi SA; El-Ghani HMA
    Acta Trop; 2024 May; 256():107263. PubMed ID: 38768696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran.
    Mahmoudvand H; Saedi Dezaki E; Soleimani S; Baneshi MR; Kheirandish F; Ezatpour B; Zia-Ali N
    Parasite Immunol; 2015 Jul; 37(7):362-7. PubMed ID: 25891186
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Foroutan M; Majidiani H; Hassanipour S; Badri M
    Heliyon; 2024 Mar; 10(6):e28013. PubMed ID: 38509978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Immunological Impacts of Latent Toxoplasmosis on COVID-19 Patients.
    Habib S; Hamza E; El-Gamal R; Nosser NA; Aboukamar WA; Abdelsalam S; Sobh A; Elegezy M; Elbayoumy M; Eldars W; Elmasry K; Elnagdy MH
    Cureus; 2023 Sep; 15(9):e45989. PubMed ID: 37900421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Toxoplasma gondii infection and psychiatric disorders in Iran: A systematic review with meta-analysis.
    Montazeri M; Moradi E; Moosazadeh M; Hosseini SH; Fakhar M
    PLoS One; 2023; 18(8):e0284954. PubMed ID: 37552680
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Liu YM; Zhang YY; Wang L; Wang HY; Li CH; Jiang YH; Sun WW
    Pathogens; 2022 Sep; 11(10):. PubMed ID: 36297135
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxoplasmosis Immunity Status of Blood Donors in Sidi Bel Abbès, West Algeria.
    Belkacemi M; Heddi B
    Cureus; 2022 Sep; 14(9):e28826. PubMed ID: 36225427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seronegative Infection with
    Pawełczyk A; Bednarska M; Caraballo Cortés K; Glamkowska-Sady M; Kowalska J; Uszyńska-Kałuża B; Radkowski M; Welc-Falęciak R
    J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Contribution of ABO, Lewis and Secretor Histo-Blood Group Carbohydrates in Infection by
    De Mattos LC; Ferreira AIC; de Oliveira KY; Nakashima F; Brandão CC
    Front Cell Infect Microbiol; 2021; 11():671958. PubMed ID: 34222043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of Toxoplasma gondii among healthy blood donors in two locations in Tunisia and associated risk factors.
    Lachkhem A; Lahmar I; Galal L; Babba O; Mezhoud H; Hassine M; Lachkhem A; Dardé ML; Mercier A; Babba H
    Parasite; 2020; 27():51. PubMed ID: 32955429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Prevalence of Antibodies Against
    Xin S; Su R; Jiang N; Zhang L; Yang Y
    Front Cell Infect Microbiol; 2020; 10():302. PubMed ID: 32656100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.